Skip to main content
. 2019 Feb 1;34(2):76–83. doi: 10.1097/YIC.0000000000000246

Table 4.

Change from baseline to the end of open-label treatment in clinical laboratory and cardiovascular parameters (safety population)

graphic file with name yic-34-76-g005.jpg